Equity Profile

CPRX

Catalyst Pharmaceuticals, Inc.

Health CareBiotechnology$3.9B

Aug5Wed

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Catalyst Pharmaceuticals, Inc. (CPRX) is a biotechnology company focused on developing and commercializing innovative therapies for rare diseases....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and investor sentiment.

$0.74

Revenue

Revenue growth reflects the company's ability to generate sales and expand its market presence.

$155M

Wall Street expectations, options signals, track record, and call prep available with Pro.

CPRX Q2-2026 Earnings Preview

Context

Company Snapshot

Catalyst Pharmaceuticals, Inc. (CPRX) is a biotechnology company focused on developing and commercializing innovative therapies for rare diseases. With a market cap of $4 billion, its work is crucial in addressing unmet medical needs in the healthcare sector.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+36.69%

Avg Stock Reaction

+0.67%

Last Quarter Recap

In Q1-2026, Catalyst Pharmaceuticals reported an EPS of $0.79, exceeding estimates by 36.21%. The stock remained stable the following day, indicating cautious investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Catalyst to report solid earnings, with a consensus EPS of $0.74 and revenue of $155 million. The company has a strong track record of beating earnings expectations.

Bull Case

If Catalyst continues its trend of exceeding EPS estimates, it could signal strong operational performance and investor confidence, potentially leading to a stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price, especially given the high implied volatility in the options market.

Key Metrics to Watch

EPS

$0.74

Earnings per share is a key indicator of profitability and investor sentiment.

Revenue

$155M

Revenue growth reflects the company's ability to generate sales and expand its market presence.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $0.74?

A beat on EPS could reinforce the company's strong performance history and boost investor confidence.

What guidance will management provide for future revenue growth?

Future revenue guidance will be critical in assessing the company's growth trajectory and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for revenue growth driven by new product launches, which could exceed current projections.

Supporting Evidence

Catalyst has consistently beaten EPS estimates, indicating stronger-than-expected demand for its products.

The options market's high implied volatility suggests that investors are anticipating significant news that could drive the stock in either direction.

Key Risk

If revenue growth exceeds $160 million, it could challenge the current consensus and lead to upward revisions.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching the balance between strong historical performance and future growth potential.

Bull Confirmed If

An EPS of $0.80 or higher would confirm strong operational momentum and support the bull case.

Bear Confirmed If

An EPS below $0.70 would raise concerns about profitability and could confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.68%

Historical Avg

±1.4%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±5.7% while CPRX has averaged ±1.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

36.4%

Calls (5K)P/C Ratio: 0.01Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Catalyst beats expectations, history suggests the stock could rise by around +0.67%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss on EPS could lead to a decline in stock price, with historical patterns suggesting a potential drop around -1.94%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into customer feedback and demand trends for existing products.
4Guidance on future R&D initiatives and their timelines.
5Any strategic partnerships or collaborations that may enhance growth prospects.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Catalyst Pharmaceuticals, Inc. (CPRX) is a biotechnology company focused on developing and commercializing innovative therapies for rare diseases....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and investor sentiment.

$0.74

Revenue

Revenue growth reflects the company's ability to generate sales and expand its market presence.

$155M

Wall Street expectations, options signals, track record, and call prep available with Pro.

CPRX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+36.69%

Avg Stock Reaction

+0.67%

Last Quarter Recap

In Q1-2026, Catalyst Pharmaceuticals reported an EPS of $0.79, exceeding estimates by 36.21%. The stock remained stable the following day, indicating cautious investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Catalyst to report solid earnings, with a consensus EPS of $0.74 and revenue of $155 million. The company has a strong track record of beating earnings expectations.

Bull Case

If Catalyst continues its trend of exceeding EPS estimates, it could signal strong operational performance and investor confidence, potentially leading to a stock price increase.

Bear Case

Conversely, if the company fails to meet expectations or provides weak guidance, it could lead to a decline in stock price, especially given the high implied volatility in the options market.

Key Metrics to Watch

EPS

$0.74

Earnings per share is a key indicator of profitability and investor sentiment.

Revenue

$155M

Revenue growth reflects the company's ability to generate sales and expand its market presence.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $0.74?

A beat on EPS could reinforce the company's strong performance history and boost investor confidence.

What guidance will management provide for future revenue growth?

Future revenue guidance will be critical in assessing the company's growth trajectory and market position.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the potential for revenue growth driven by new product launches, which could exceed current projections.

Supporting Evidence

Catalyst has consistently beaten EPS estimates, indicating stronger-than-expected demand for its products.

The options market's high implied volatility suggests that investors are anticipating significant news that could drive the stock in either direction.

Key Risk

If revenue growth exceeds $160 million, it could challenge the current consensus and lead to upward revisions.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is closely watching the balance between strong historical performance and future growth potential.

Bull Confirmed If

An EPS of $0.80 or higher would confirm strong operational momentum and support the bull case.

Bear Confirmed If

An EPS below $0.70 would raise concerns about profitability and could confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5.68%

Historical Avg

±1.4%

Pricing rich

The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings report.

Options are pricing ±5.7% while CPRX has averaged ±1.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

36.4%

Calls (5K)P/C Ratio: 0.01Puts (0)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Catalyst beats expectations, history suggests the stock could rise by around +0.67%, confirming strong operational performance.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss on EPS could lead to a decline in stock price, with historical patterns suggesting a potential drop around -1.94%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market conditions and competitive landscape.
3Insights into customer feedback and demand trends for existing products.
4Guidance on future R&D initiatives and their timelines.
5Any strategic partnerships or collaborations that may enhance growth prospects.